10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ETON (Eton Pharmaceuticals Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Eton Pharmaceuticals Inc together

I guess you are interested in Eton Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Eton Pharmaceuticals Inc’s Financial Insights
  • 📈 Technical Analysis (TA) – Eton Pharmaceuticals Inc’s Price Targets

I'm going to help you getting a better view of Eton Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Eton Pharmaceuticals Inc

I send you an email if I find something interesting about Eton Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Eton Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Eton Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
9.7%

What is your share worth?

Current worth
$0.89
Expected worth in 1 year
$1.28
How sure are you?
38.7%

+ What do you gain per year?

Total Gains per Share
$0.39
Return On Investment
2.2%

For what price can you sell your share?

Current Price per Share
$17.56
Expected price per share
$16.27 - $21.48
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Eton Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$17.56
Intrinsic Value Per Share
$11.58 - $13.91
Total Value Per Share
$12.47 - $14.80

2.2. Growth of Eton Pharmaceuticals Inc (5 min.)




Is Eton Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$23.9m$15.3m$6.8m31.0%

How much money is Eton Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$1.6m$639.7k62.0%
Net Profit Margin-5.5%-20.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Eton Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Eton Pharmaceuticals Inc?

Welcome investor! Eton Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Eton Pharmaceuticals Inc.

First you should know what it really means to hold a share of Eton Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Eton Pharmaceuticals Inc is $17.56. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Eton Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Eton Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.89. Based on the TTM, the Book Value Change Per Share is $0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Eton Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-0.5%-0.04-0.2%-0.06-0.4%-0.03-0.2%-0.06-0.4%-0.14-0.8%
Usd Book Value Change Per Share-0.02-0.1%0.100.6%-0.03-0.2%0.030.2%0.030.2%0.030.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-0.1%0.100.6%-0.03-0.2%0.030.2%0.030.2%0.030.2%
Usd Price Per Share14.25-11.64-3.90-6.20-6.01-5.33-
Price to Earnings Ratio-37.06--44.44--24.89--22.15--14.33--11.25-
Price-to-Total Gains Ratio-773.62--2,326.58-1,614.71--239.51--177.94--86.02-
Price to Book Ratio15.99-13.74-6.81-8.98-16.03-13.35-
Price-to-Total Gains Ratio-773.62--2,326.58-1,614.71--239.51--177.94--86.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share17.56
Number of shares56
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.100.03
Usd Total Gains Per Share0.100.03
Gains per Quarter (56 shares)5.451.76
Gains per Year (56 shares)21.787.04
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10221207-3
2044340144
30655602111
40877802818
5010910003525
6013112204232
7015214404939
8017416605646
9019618806353
10021821007060

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%5.026.00.016.1%5.026.00.016.1%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%12.019.00.038.7%12.019.00.038.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%3.00.028.09.7%3.00.028.09.7%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%12.019.00.038.7%12.019.00.038.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Eton Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0180.097-119%-0.030+65%0.033-156%0.031-159%0.029-164%
Book Value Per Share--0.8910.827+8%0.572+56%0.628+42%0.599+49%0.553+61%
Current Ratio--1.7731.827-3%1.812-2%2.206-20%3.771-53%5.795-69%
Debt To Asset Ratio--0.7640.677+13%0.513+49%0.559+37%0.511+50%0.409+87%
Debt To Equity Ratio--3.2432.260+44%1.067+204%1.427+127%1.432+127%1.048+209%
Dividend Per Share----0%-0%-0%-0%0.003-100%
Enterprise Value--330889250.000279865907.500+18%107833456.250+207%158029333.750+109%159709992.750+107%165997812.222+99%
Eps---0.096-0.038-60%-0.062-35%-0.034-64%-0.064-34%-0.136+41%
Ev To Ebitda Ratio---56.083-24.995-55%-40.145-28%-21.302-62%-19.316-66%-17.522-69%
Ev To Sales Ratio--4.3704.898-11%3.511+24%3.972+10%25.843-83%120.564-96%
Free Cash Flow Per Share--0.2960.055+434%-0.024+108%0.025+1089%-0.017+106%-0.062+121%
Free Cash Flow To Equity Per Share--0.2960.368-20%-0.036+112%0.125+137%0.086+243%0.138+114%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--13.909----------
Intrinsic Value_10Y_min--11.580----------
Intrinsic Value_1Y_max--0.287----------
Intrinsic Value_1Y_min--0.282----------
Intrinsic Value_3Y_max--1.706----------
Intrinsic Value_3Y_min--1.612----------
Intrinsic Value_5Y_max--4.142----------
Intrinsic Value_5Y_min--3.772----------
Market Cap470915300.000+19%383225250.000312579907.500+23%104521206.250+267%166432250.417+130%161298242.750+138%143069868.710+168%
Net Profit Margin---0.137-0.055-60%-0.207+52%-0.175+28%-3.365+2364%-13.416+9723%
Operating Margin---0.009-100%-0.1820%-0.1370%-3.2170%-12.9630%
Operating Ratio--1.0781.000+8%1.194-10%1.142-6%4.136-74%13.685-92%
Pb Ratio19.709+19%15.99413.740+16%6.814+135%8.984+78%16.0320%13.351+20%
Pe Ratio-45.671-23%-37.062-44.435+20%-24.889-33%-22.147-40%-14.325-61%-11.252-70%
Price Per Share17.560+19%14.25011.638+22%3.898+266%6.200+130%6.011+137%5.333+167%
Price To Free Cash Flow Ratio14.834+19%12.03713.022-8%-7.964+166%0.811+1384%-4.318+136%-5.398+145%
Price To Total Gains Ratio-953.318-23%-773.621-2326.583+201%1614.707-148%-239.508-69%-177.941-77%-86.017-89%
Quick Ratio--1.0321.173-12%1.648-37%1.850-44%3.209-68%5.207-80%
Return On Assets---0.025-0.009-66%-0.053+108%-0.028+9%-0.080+214%-0.165+547%
Return On Equity---0.108-0.039-64%-0.115+6%-0.068-37%-0.336+211%-0.372+245%
Total Gains Per Share---0.0180.097-119%-0.030+65%0.033-156%0.031-159%0.032-158%
Usd Book Value--23961000.00022205000.000+8%15331250.000+56%16864166.667+42%16081350.000+49%14821903.226+62%
Usd Book Value Change Per Share---0.0180.097-119%-0.030+65%0.033-156%0.031-159%0.029-164%
Usd Book Value Per Share--0.8910.827+8%0.572+56%0.628+42%0.599+49%0.553+61%
Usd Dividend Per Share----0%-0%-0%-0%0.003-100%
Usd Enterprise Value--330889250.000279865907.500+18%107833456.250+207%158029333.750+109%159709992.750+107%165997812.222+99%
Usd Eps---0.096-0.038-60%-0.062-35%-0.034-64%-0.064-34%-0.136+41%
Usd Free Cash Flow--7959000.0001493000.000+433%-653750.000+108%669750.000+1088%-467850.000+106%-1651000.000+121%
Usd Free Cash Flow Per Share--0.2960.055+434%-0.024+108%0.025+1089%-0.017+106%-0.062+121%
Usd Free Cash Flow To Equity Per Share--0.2960.368-20%-0.036+112%0.125+137%0.086+243%0.138+114%
Usd Market Cap470915300.000+19%383225250.000312579907.500+23%104521206.250+267%166432250.417+130%161298242.750+138%143069868.710+168%
Usd Price Per Share17.560+19%14.25011.638+22%3.898+266%6.200+130%6.011+137%5.333+167%
Usd Profit---2585000.000-1032000.000-60%-1671750.000-35%-954250.000-63%-1736400.000-33%-2798629.032+8%
Usd Revenue--18928000.00014545250.000+30%7845250.000+141%9881666.667+92%7493300.000+153%4869161.290+289%
Usd Total Gains Per Share---0.0180.097-119%-0.030+65%0.033-156%0.031-159%0.032-158%
 EOD+4 -4MRQTTM+14 -23YOY+24 -133Y+19 -185Y+20 -1710Y+22 -17

3.3 Fundamental Score

Let's check the fundamental score of Eton Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-45.671
Price to Book Ratio (EOD)Between0-119.709
Net Profit Margin (MRQ)Greater than0-0.137
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.032
Current Ratio (MRQ)Greater than11.773
Debt to Asset Ratio (MRQ)Less than10.764
Debt to Equity Ratio (MRQ)Less than13.243
Return on Equity (MRQ)Greater than0.15-0.108
Return on Assets (MRQ)Greater than0.05-0.025
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Eton Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.620
Ma 20Greater thanMa 5017.368
Ma 50Greater thanMa 10016.130
Ma 100Greater thanMa 20016.321
OpenGreater thanClose17.760
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Fundamental data was last updated by Penke on 2025-09-03 21:52:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Eton Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -13.7% means that $-0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Eton Pharmaceuticals Inc:

  • The MRQ is -13.7%. The company is making a huge loss. -2
  • The TTM is -5.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-13.7%TTM-5.5%-8.2%
TTM-5.5%YOY-20.7%+15.2%
TTM-5.5%5Y-336.5%+331.0%
5Y-336.5%10Y-1,341.6%+1,005.1%
4.3.1.2. Return on Assets

Shows how efficient Eton Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.5% Return on Assets means that Eton Pharmaceuticals Inc generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Eton Pharmaceuticals Inc:

  • The MRQ is -2.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.5%TTM-0.9%-1.7%
TTM-0.9%YOY-5.3%+4.4%
TTM-0.9%5Y-8.0%+7.1%
5Y-8.0%10Y-16.5%+8.5%
4.3.1.3. Return on Equity

Shows how efficient Eton Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -10.8% Return on Equity means Eton Pharmaceuticals Inc generated $-0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Eton Pharmaceuticals Inc:

  • The MRQ is -10.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.8%TTM-3.9%-6.9%
TTM-3.9%YOY-11.5%+7.5%
TTM-3.9%5Y-33.6%+29.7%
5Y-33.6%10Y-37.2%+3.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Eton Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Eton Pharmaceuticals Inc is operating .

  • Measures how much profit Eton Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Eton Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.9%-0.9%
TTM0.9%YOY-18.2%+19.0%
TTM0.9%5Y-321.7%+322.5%
5Y-321.7%10Y-1,296.3%+974.6%
4.3.2.2. Operating Ratio

Measures how efficient Eton Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are $1.08 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.078. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.000. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.078TTM1.000+0.077
TTM1.000YOY1.194-0.193
TTM1.0005Y4.136-3.136
5Y4.13610Y13.685-9.549
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Eton Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Eton Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.77 means the company has $1.77 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.773. The company is able to pay all its short-term debts. +1
  • The TTM is 1.827. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.773TTM1.827-0.054
TTM1.827YOY1.812+0.015
TTM1.8275Y3.771-1.944
5Y3.77110Y5.795-2.024
4.4.3.2. Quick Ratio

Measures if Eton Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.03 means the company can pay off $1.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.032. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.173. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.032TTM1.173-0.141
TTM1.173YOY1.648-0.474
TTM1.1735Y3.209-2.036
5Y3.20910Y5.207-1.998
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Eton Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Eton Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Eton Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.76 means that Eton Pharmaceuticals Inc assets are financed with 76.4% credit (debt) and the remaining percentage (100% - 76.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 0.764. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.677. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.764TTM0.677+0.088
TTM0.677YOY0.513+0.164
TTM0.6775Y0.511+0.166
5Y0.51110Y0.409+0.102
4.5.4.2. Debt to Equity Ratio

Measures if Eton Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 324.3% means that company has $3.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 3.243. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.260. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.243TTM2.260+0.984
TTM2.260YOY1.067+1.193
TTM2.2605Y1.432+0.828
5Y1.43210Y1.048+0.383
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Eton Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -37.06 means the investor is paying $-37.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is -45.671. Based on the earnings, the company is expensive. -2
  • The MRQ is -37.062. Based on the earnings, the company is expensive. -2
  • The TTM is -44.435. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-45.671MRQ-37.062-8.609
MRQ-37.062TTM-44.435+7.373
TTM-44.435YOY-24.889-19.546
TTM-44.4355Y-14.325-30.110
5Y-14.32510Y-11.252-3.073
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is 14.834. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 12.037. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 13.022. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD14.834MRQ12.037+2.796
MRQ12.037TTM13.022-0.985
TTM13.022YOY-7.964+20.987
TTM13.0225Y-4.318+17.340
5Y-4.31810Y-5.398+1.080
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Eton Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is 19.709. Based on the equity, the company is expensive. -2
  • The MRQ is 15.994. Based on the equity, the company is expensive. -2
  • The TTM is 13.740. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD19.709MRQ15.994+3.715
MRQ15.994TTM13.740+2.254
TTM13.740YOY6.814+6.926
TTM13.7405Y16.032-2.292
5Y16.03210Y13.351+2.681
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Eton Pharmaceuticals Inc.

4.8.1. Institutions holding Eton Pharmaceuticals Inc

Institutions are holding 62.473% of the shares of Eton Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Opaleye Management Inc10.66478.2476286000079300.278
2025-06-30EcoR1 Capital, LLC7.57171.71282030544912564.7056
2025-06-30Vanguard Group Inc4.8930.0003131217321121019.1841
2025-06-30Nantahala Capital Management, LLC4.3850.6566117595100
2025-06-30Westside Investment Management, Inc.1.7631.2495472790-20860-4.2257
2025-03-31Susquehanna International Group, LLP1.67350.001448804256478133.3559
2025-03-31Acadian Asset Management LLC1.50060.01484024284024280
2025-06-30Cannell Capital LLC1.44751.6548388175-303192-43.854
2025-06-30Thompson, Siegel & Walmsley LLC1.42170.0904381265191402100.8106
2025-03-31Millennium Management LLC1.32720.0025355929217042156.2724
2025-03-31BlackRock Inc1.28780.0001345360277358.732
2025-03-31Stifel Financial Corp1.19320.00443199903199900
2025-03-31Geode Capital Management, LLC1.11210.00032982482960211.019
2025-06-30Soleus Capital Management, L.P.1.06270.26892850002850000
2025-03-31Renaissance Technologies Corp1.02170.00542740008090041.8954
2025-03-31Aristides Capital LLC0.90090.925324158700
2025-06-30Connor Clark & Lunn Inv Mgmt Ltd0.82810.0112222083-10449-4.4936
2025-06-30Two Sigma Investments LLC0.80.0054214552132197160.5209
2025-03-31Morgan Stanley - Brokerage Accounts0.54940.00011473321341391016.7437
2025-06-30Bridgeway Capital Management, LLC0.50440.045813527000
Total 45.908214.897212311481+2052808+16.7%

4.9.2. Funds holding Eton Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Vanguard Total Stock Mkt Idx Inv2.55910.0005686276-15228-2.1708
2025-07-31iShares Russell 2000 ETF2.28160.0143611880-11655-1.8692
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr1.02680.0049275361-119331-30.234
2025-07-31iShares Russell 2000 Growth ETF0.83040.02722268100
2025-06-30Fidelity Extended Market Index0.51690.005138622-362-0.2605
2025-07-31Vanguard Russell 2000 ETF0.45620.0138122348-8184-6.2697
2025-06-30Bridgeway Ultra-Small Company0.39551.744710607000
2025-07-31State St Russell Sm Cap® Indx SL Cl I0.33750.01419050000
2025-07-31Schwab Small Cap Index0.24080.0146458300
2025-06-30Calamos Timpani Small Cap Growth I0.23820.2089638698331.3215
2025-06-30Timpani Small Cap Growth Equity0.23820.208963869638690
2025-07-31State St Russell Sm/Mid Cp® Indx SL Cl I0.23160.00262100621000
2025-06-30NT R2000 Index Fund - NL0.23140.014362051620510
2025-07-31iShares Micro-Cap ETF0.21670.09865811400
2025-06-30Extended Equity Market Fund K0.20070.005353835-1074-1.956
2025-07-31iShares Core S&P Total US Stock Mkt ETF0.18560.00149779150.0301
2025-06-30NT R2000 Index Fund - DC - NL - 30.18450.014349472494720
2025-06-30Fidelity Total Market Index0.17740.00064756100
2025-07-31iShares Russell 2000 Small-Cap Idx Instl0.16560.014344417408310.123
2025-07-31SPDR® Russell 2000 US Small Cap ETF0.14620.014392101161042.0652
Total 10.86092.42052912598+98199+3.4%

5.3. Insider Transactions

Insiders are holding 4.388% of the shares of Eton Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-08-20James R GruberSELL263116.02
2025-08-19James R GruberSELL3908216.16
2025-06-16David KrempaSELL1022314.73
2025-06-13David KrempaSELL680014.77
2025-06-12David KrempaSELL1697714.92
2024-10-07Opaleye Management Inc.BUY112487.22
2024-10-04Opaleye Management Inc.BUY168526.77
2024-09-10Opaleye Management Inc.BUY575004.65
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets101,676
Total Liabilities77,715
Total Stockholder Equity23,961
 As reported
Total Liabilities 77,715
Total Stockholder Equity+ 23,961
Total Assets = 101,676

Assets

Total Assets101,676
Total Current Assets68,443
Long-term Assets33,233
Total Current Assets
Cash And Cash Equivalents 25,379
Net Receivables 14,453
Inventory 23,791
Other Current Assets 4,820
Total Current Assets  (as reported)68,443
Total Current Assets  (calculated)68,443
+/-0
Long-term Assets
Property Plant Equipment 342
Intangible Assets 32,879
Long-term Assets Other 12
Long-term Assets  (as reported)33,233
Long-term Assets  (calculated)33,233
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities38,596
Long-term Liabilities39,119
Total Stockholder Equity23,961
Total Current Liabilities
Short-term Debt 2,792
Short Long Term Debt 2,769
Accounts payable 12,142
Other Current Liabilities 23,332
Total Current Liabilities  (as reported)38,596
Total Current Liabilities  (calculated)41,035
+/- 2,439
Long-term Liabilities
Long term Debt 27,409
Capital Lease Obligations 492
Long-term Liabilities Other 4,269
Long-term Liabilities  (as reported)39,119
Long-term Liabilities  (calculated)32,170
+/- 6,949
Total Stockholder Equity
Common Stock27
Retained Earnings -112,050
Other Stockholders Equity 135,984
Total Stockholder Equity (as reported)23,961
Total Stockholder Equity (calculated)23,961
+/-0
Other
Capital Stock27
Cash and Short Term Investments 25,379
Common Stock Shares Outstanding 26,893
Current Deferred Revenue330
Liabilities and Stockholders Equity 101,676
Net Debt -22,118
Net Invested Capital 54,139
Net Working Capital 29,847
Property Plant and Equipment Gross 342
Short Long Term Debt Total 3,261



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
0
0
13,443
11,712
9,646
7,525
28,327
23,017
18,244
13,507
17,072
17,241
14,559
11,395
26,319
31,186
29,906
26,606
27,465
23,196
23,046
21,520
25,030
23,928
30,932
31,526
31,740
30,794
31,823
35,841
76,123
84,032
101,676
101,67684,03276,12335,84131,82330,79431,74031,52630,93223,92825,03021,52023,04623,19627,46526,60629,90631,18626,31911,39514,55917,24117,07213,50718,24423,01728,3277,5259,64611,71213,44300
   > Total Current Assets 
0
0
13,292
11,353
9,162
6,803
27,502
21,527
16,755
12,107
15,009
15,341
12,823
9,785
24,701
30,274
29,075
25,863
23,604
18,751
19,776
16,420
20,004
19,118
26,333
27,157
26,839
24,263
25,434
29,749
41,021
49,960
68,443
68,44349,96041,02129,74925,43424,26326,83927,15726,33319,11820,00416,42019,77618,75123,60425,86329,07530,27424,7019,78512,82315,34115,00912,10716,75521,52727,5026,8039,16211,35313,29200
       Cash And Cash Equivalents 
0
0
13,156
11,215
8,946
6,603
26,735
19,584
14,947
11,777
12,066
12,335
10,270
7,332
21,295
25,113
25,802
22,709
14,406
15,229
17,046
13,378
16,305
14,708
21,566
22,070
21,388
16,655
17,694
20,261
14,936
17,420
25,379
25,37917,42014,93620,26117,69416,65521,38822,07021,56614,70816,30513,37817,04615,22914,40622,70925,80225,11321,2957,33210,27012,33512,06611,77714,94719,58426,7356,6038,94611,21513,15600
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
473
205
-844
-754
48
300
303
385
5,471
796
834
1,498
1,852
2,874
3,084
3,495
3,411
4,240
4,873
5,591
5,361
16,400
14,453
14,45316,4005,3615,5914,8734,2403,4113,4953,0842,8741,8521,4988347965,47138530330048-754-8442054730000000000
       Other Current Assets 
0
0
136
138
216
200
767
3,886
1,808
660
3,180
2,150
1,688
1,508
4,232
3,513
3,456
4,870
6,354
4,432
2,730
2,126
1,290
1,099
867
541
1,129
1,050
799
1,959
5,492
2,519
4,820
4,8202,5195,4921,9597991,0501,1295418671,0991,2902,1262,7304,4326,3544,8703,4563,5134,2321,5081,6882,1503,1806601,8083,88676720021613813600
   > Long-term Assets 
0
0
151
359
484
722
825
1,490
1,489
1,400
2,063
1,900
1,736
1,610
1,618
912
831
743
3,861
4,445
3,270
5,100
5,026
4,810
4,599
4,369
4,901
6,531
6,389
6,092
35,102
34,072
33,233
33,23334,07235,1026,0926,3896,5314,9014,3694,5994,8105,0265,1003,2704,4453,8617438319121,6181,6101,7361,9002,0631,4001,4891,49082572248435915100
       Property Plant Equipment 
0
0
119
203
233
268
773
1,442
1,445
1,360
1,277
1,154
1,034
917
1,003
339
299
257
219
193
150
115
260
225
195
147
150
131
255
226
209
180
342
3421802092262551311501471952252601151501932192572993391,0039171,0341,1541,2771,3601,4451,44277326823320311900
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
725
688
650
612
575
537
500
463
3,621
4,240
3,108
4,973
4,754
4,573
4,392
4,210
4,739
6,388
6,122
5,854
34,881
33,880
32,879
32,87933,88034,8815,8546,1226,3884,7394,2104,3924,5734,7544,9733,1084,2403,6214635005375756126506887250000000000
       Other Assets 
0
0
32
156
251
454
52
48
44
40
61
58
52
81
232
36
32
23
21
12
12
12
12
0
12
0
0
0
0
0
0
0
0
00000000120121212122123323623281525861404448524542511563200
> Total Liabilities 
0
0
793
1,550
2,150
2,774
2,024
3,775
1,545
1,159
6,522
6,621
7,528
10,007
10,656
9,631
9,170
10,946
9,835
9,813
9,804
10,339
11,952
12,687
14,207
14,634
16,263
15,300
18,361
19,860
51,695
59,582
77,715
77,71559,58251,69519,86018,36115,30016,26314,63414,20712,68711,95210,3399,8049,8139,83510,9469,1709,63110,65610,0077,5286,6216,5221,1591,5453,7752,0242,7742,1501,55079300
   > Total Current Liabilities 
0
0
793
947
1,134
1,197
2,024
3,656
1,459
1,107
1,963
2,051
2,739
3,219
3,794
3,199
3,106
5,360
4,558
3,482
3,812
4,661
6,461
7,494
9,588
10,393
16,241
15,300
18,216
19,734
19,947
25,350
38,596
38,59625,35019,94719,73418,21615,30016,24110,3939,5887,4946,4614,6613,8123,4824,5585,3603,1063,1993,7943,2192,7392,0511,9631,1071,4593,6562,0241,1971,13494779300
       Short-term Debt 
0
0
0
0
0
0
0
123
0
0
0
0
159
219
280
726
749
1,092
1,418
0
364
708
1,033
1,339
1,540
1,540
5,433
5,107
4,732
4,125
0
0
2,792
2,792004,1254,7325,1075,4331,5401,5401,3391,03370836401,4181,09274972628021915900001230000000
       Short Long Term Debt 
0
0
0
0
0
0
0
123
0
0
0
0
159
219
280
726
749
1,092
1,418
0
364
708
1,033
1,339
1,540
1,540
5,380
5,020
4,658
4,125
0
0
2,769
2,769004,1254,6585,0205,3801,5401,5401,3391,03370836401,4181,09274972628021915900001230000000
       Accounts payable 
0
0
539
801
868
793
1,421
3,208
883
549
575
1,183
1,953
2,208
2,344
1,761
1,522
3,273
1,774
2,131
1,299
1,054
1,766
1,233
2,300
1,712
1,848
2,263
2,133
2,684
4,167
4,872
12,142
12,1424,8724,1672,6842,1332,2631,8481,7122,3001,2331,7661,0541,2992,1311,7743,2731,5221,7612,3442,2081,9531,1835755498833,2081,42179386880153900
       Other Current Liabilities 
0
0
254
146
266
404
603
448
576
558
1,388
868
627
792
1,170
712
835
995
1,366
1,351
2,149
2,899
3,662
4,922
5,748
7,141
8,960
7,930
11,351
12,925
15,780
20,478
23,332
23,33220,47815,78012,92511,3517,9308,9607,1415,7484,9223,6622,8992,1491,3511,3669958357121,1707926278681,38855857644860340426614625400
   > Long-term Liabilities 
0
0
0
603
1,016
1,577
1,421
119
86
52
4,559
4,570
4,789
6,788
6,862
6,432
6,064
5,586
5,277
6,331
5,992
5,678
5,491
5,193
4,619
4,241
22
0
145
126
31,748
34,232
39,119
39,11934,23231,7481261450224,2414,6195,1935,4915,6785,9926,3315,2775,5866,0646,4326,8626,7884,7894,5704,55952861191,4211,5771,016603000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
4,540
4,570
4,587
6,496
6,532
6,183
5,856
0
0
0
0
5,678
5,384
5,107
0
0
0
0
0
0
0
0
0
0000000005,1075,3845,67800005,8566,1836,5326,4964,5874,5704,5400000000000
       Warrants
0
0
0
0
0
21,161
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000021,16100000
       Other Liabilities 
0
0
520
603
1,016
1,577
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000001,5771,01660352000
       Deferred Long Term Liability 
0
0
0
0
0
397
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000039700000
> Total Stockholder Equity
0
0
12,130
10,162
7,496
4,751
26,303
19,242
16,699
12,348
10,550
10,620
7,031
1,388
15,663
21,555
20,736
15,660
17,630
13,383
13,242
11,181
13,078
11,241
16,725
16,892
15,477
15,494
13,462
15,981
24,428
24,450
23,961
23,96124,45024,42815,98113,46215,49415,47716,89216,72511,24113,07811,18113,24213,38317,63015,66020,73621,55515,6631,3887,03110,62010,55012,34816,69919,24226,3034,7517,49610,16212,13000
   Common Stock
0
0
6
6
6
6
18
18
18
18
18
21
21
21
24
24
25
25
25
25
25
25
25
26
26
26
26
26
26
26
27
27
27
272727262626262626262525252525252524242121211818181818666600
   Retained Earnings Total Equity00000000-101,235-105,794-103,134-104,0460000-89,058-87,042-92,158-84,471-77,967-73,237-64,188-61,492-56,527-53,278-45,868-19,80600000
   Accumulated Other Comprehensive Income 00000000000000000000-519-432-3450-17300-21,161-20,432-19,710000
   Capital Surplus 
0
0
0
0
0
3,390
72,153
72,502
73,208
73,822
74,720
83,836
84,977
85,838
107,797
108,573
109,769
0
0
0
0
115,202
116,187
117,009
117,934
0
0
0
0
0
0
0
0
00000000117,934117,009116,187115,2020000109,769108,573107,79785,83884,97783,83674,72073,82273,20872,50272,1533,39000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
0
0
1,759
2,809
3,225
3,390
72,153
72,502
73,208
73,822
74,720
83,836
84,977
85,838
107,797
108,573
109,769
110,787
111,718
112,801
114,218
115,202
116,187
117,009
117,934
118,680
119,521
120,349
121,358
123,250
132,294
133,888
135,984
135,984133,888132,294123,250121,358120,349119,521118,680117,934117,009116,187115,202114,218112,801111,718110,787109,769108,573107,79785,83884,97783,83674,72073,82273,20872,50272,1533,3903,2252,8091,75900



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue39,011
Cost of Revenue-15,600
Gross Profit23,41123,411
 
Operating Income (+$)
Gross Profit23,411
Operating Expense-26,008
Operating Income-2,597-2,597
 
Operating Expense (+$)
Research Development3,255
Selling General Administrative22,753
Selling And Marketing Expenses0
Operating Expense26,00826,008
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,005
Other Finance Cost-794
Net Interest Income-1,211
 
Pretax Income (+$)
Operating Income-2,597
Net Interest Income-1,211
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,808-1,386
EBIT - interestExpense = -4,602
-3,808
-1,818
Interest Expense2,005
Earnings Before Interest and Taxes (EBIT)-2,597-1,803
Earnings Before Interest and Taxes (EBITDA)-1,451
 
After tax Income (+$)
Income Before Tax-3,808
Tax Provision-15
Net Income From Continuing Ops-3,823-3,823
Net Income-3,823
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses41,608
Total Other Income/Expenses Net-1,2111,211
 

Technical Analysis of Eton Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Eton Pharmaceuticals Inc. The general trend of Eton Pharmaceuticals Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Eton Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Eton Pharmaceuticals Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Eton Pharmaceuticals Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 18.31 < 21.10 < 21.48.

The bearish price targets are: 17.54 > 16.69 > 16.27.

Know someone who trades $ETON? Share this with them.👇

Eton Pharmaceuticals Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Eton Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Eton Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Eton Pharmaceuticals Inc. The current macd is 0.42446285.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Eton Pharmaceuticals Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Eton Pharmaceuticals Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Eton Pharmaceuticals Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Eton Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartEton Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Eton Pharmaceuticals Inc. The current adx is 25.08.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Eton Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Eton Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Eton Pharmaceuticals Inc. The current sar is 17.24.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Eton Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Eton Pharmaceuticals Inc. The current rsi is 57.62. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Eton Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartEton Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Eton Pharmaceuticals Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Eton Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Eton Pharmaceuticals Inc Daily Stochastic Oscillator ChartEton Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Eton Pharmaceuticals Inc. The current cci is 59.79.

Eton Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartEton Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Eton Pharmaceuticals Inc. The current cmo is 10.09.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Eton Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartEton Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Eton Pharmaceuticals Inc. The current willr is -52.39163748.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Eton Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Eton Pharmaceuticals Inc Daily Williams %R ChartEton Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Eton Pharmaceuticals Inc. The current atr is 0.7409954.

Eton Pharmaceuticals Inc Daily Average True Range (ATR) ChartEton Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Eton Pharmaceuticals Inc. The current obv is 10,952,709.

Eton Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartEton Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Eton Pharmaceuticals Inc. The current mfi is 62.48.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Eton Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartEton Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Eton Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-16STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Eton Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Eton Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.620
Ma 20Greater thanMa 5017.368
Ma 50Greater thanMa 10016.130
Ma 100Greater thanMa 20016.321
OpenGreater thanClose17.760
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Eton Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Eton Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Eton Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Eton Pharmaceuticals Inc

I send you an email if I find something interesting about Eton Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Eton Pharmaceuticals Inc.

Receive notifications about Eton Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.